197 related articles for article (PubMed ID: 32736708)
1. miR-182-5p inhibits the pathogenic Th17 response in experimental autoimmune uveitis mice via suppressing TAF15.
Zhang L; Sun P; Zhang Y; Xu Y; Sun Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):784-792. PubMed ID: 32736708
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated down-regulation of miR-21-5p alleviates experimental autoimmune uveoretinitis in mice.
Shi L; Guo H; Li Z; Wang Y; Wang Y; Cui Y
Int Immunopharmacol; 2019 Sep; 74():105698. PubMed ID: 31228813
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
Escobar T; Yu CR; Muljo SA; Egwuagu CE
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
[TBL] [Abstract][Full Text] [Related]
4. MiR-379-5p aggravates experimental autoimmune uveitis in mice via the regulation of SEMA3A.
Li M; Gao X; Liu K; Bao N; Jiang Z
Autoimmunity; 2021 Aug; 54(5):275-283. PubMed ID: 34060391
[TBL] [Abstract][Full Text] [Related]
5. miR-223-3p promotes autoreactive T
Wei Y; Chen S; Sun D; Li X; Wei R; Li X; Nian H
FASEB J; 2019 Dec; 33(12):13951-13965. PubMed ID: 31645142
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE
PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
8. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
9. An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation.
Chen M; Liang D; Zuo A; Shao H; Kaplan HJ; Sun D
PLoS One; 2015; 10(7):e0132348. PubMed ID: 26147733
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of microRNA in CD4
Hua M; Li J; Wang C; Shao L; Hou M; Peng J; Feng Q
Thromb Res; 2019 May; 177():70-78. PubMed ID: 30856381
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl itaconate inhibits antigen-specific Th17 cell responses and autoimmune inflammation via modulating NRF2/STAT3 signaling.
Wang Y; Yang C; Hou Y; Wang J; Zhang K; Wang L; Sun D; Li X; Wei R; Nian H
FASEB J; 2024 Apr; 38(7):e23607. PubMed ID: 38581245
[TBL] [Abstract][Full Text] [Related]
13. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
Wang RX; Yu CR; Mahdi RM; Egwuagu CE
J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
[TBL] [Abstract][Full Text] [Related]
15. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Role of rno-miR-30b-5p in IL-10 and Toll-like Receptor 4 Expressions of T Lymphocytes in Experimental Autoimmune Uveitis In Vitro.
Sun Y; Guo D; Liu B; Yin X; Wei H; Tang K; Bi H
Mediators Inflamm; 2018; 2018():2574067. PubMed ID: 30510488
[TBL] [Abstract][Full Text] [Related]
17. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
18. MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling.
Chen S; Ma B; Li X; Zhang K; Wei Y; Du B; Liu X; Wei R; Li X; Nian H
iScience; 2022 Oct; 25(10):105176. PubMed ID: 36248732
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Notch signaling pathway disturbs the CD4
Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
[TBL] [Abstract][Full Text] [Related]
20. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
